Institutional investors purchased a net $657.1 thousand shares of REGN during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 78.72% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIVIK GLOBAL HEALTHCARE LLC Bought 7.0 Thousand shares of Regeneron Pharmaceuticals...
STATE STREET GLOBAL ADVISORS FRA... Bought 5.1 Thousand shares of Regeneron Pharmaceuticals...